Latest news with #SupriyaLifescience
Fashion Value Chain
7 days ago
- Business
- Fashion Value Chain
Supriya Lifescience Leaders Shine in Hurun Women's List
A remarkable achievement for women-led enterprise, Dr. Saloni Wagh and Ms. Shivani Wagh of Supriya Lifescience Ltd. have been featured in the 2025 Candere Hurun India Women Leaders List, an annual showcase of India's most influential women in business and leadership. This year's theme, 'Celebrating Women Creating Opportunities,' perfectly reflects the leadership philosophy of both honorees. Their inclusion highlights not only their contribution to the pharmaceutical industry but also their impact in creating inclusive, purpose-driven workplaces and innovations in sustainable healthcare. Dr. Saloni Wagh, Managing Director, expressed that leadership in pharma must be anchored in innovation and responsibility. 'This recognition energizes our mission to create impactful, sustainable healthcare solutions,' she said. Ms. Shivani Wagh, Joint Managing Director, dedicated the honour to women leaders and teams that support shared progress. 'Our success stems from collaboration and commitment. It's an honour to be part of a platform that values intent as much as impact,' she added. The Candere Hurun List 2025 features women who have built over ₹2 lakh crore in self-made wealth and lead enterprises with a combined value exceeding ₹12 lakh crore. The recognition underscores excellence in entrepreneurship, leadership, and contribution to India's economic growth. This milestone comes as Supriya Lifescience celebrates its highest-ever financial year, reporting ₹696.48 crore in FY25 revenue, a 22% YoY growth. Under their joint leadership, the company continues to scale new heights in global pharma while championing ethical growth, diversity, and innovation.
Business Standard
28-05-2025
- Business
- Business Standard
Supriya Lifescience standalone net profit rises 36.42% in the March 2025 quarter
Sales rise 16.39% to Rs 184.11 crore Net profit of Supriya Lifescience rose 36.42% to Rs 50.38 crore in the quarter ended March 2025 as against Rs 36.93 crore during the previous quarter ended March 2024. Sales rose 16.39% to Rs 184.11 crore in the quarter ended March 2025 as against Rs 158.18 crore during the previous quarter ended March 2024. For the full year,net profit rose 57.80% to Rs 187.96 crore in the year ended March 2025 as against Rs 119.11 crore during the previous year ended March 2024. Sales rose 22.11% to Rs 696.49 crore in the year ended March 2025 as against Rs 570.37 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 184.11158.18 16 696.49570.37 22 OPM % 36.7135.08 - 37.4430.33 - PBDT 70.1457.08 23 268.93181.50 48 PBT 64.0653.17 20 248.49165.69 50 NP 50.3836.93 36 187.96119.11 58
